论文部分内容阅读
目的:为医疗保险部门制定医院制剂报销政策提供参考。方法:回顾性调查统计我院2013年4月制剂价格调整前后各15个月(2012年1月~2014年6月)的制剂使用情况,分析价格调整与临床用量的关系。结果:价格调整后47种制剂中,9种制剂用量增加,占19.15%;38种用量减少,占80.85%。结论:临床用量与价格调整缺乏直接联系,医院制剂仍是临床用药不可缺少的部分,亟待医疗保险部门调整制剂的医保报销政策,以降低患者负担。
Objective: To provide a reference for the medical insurance department to formulate the reimbursement policy of hospital preparations. Methods: A retrospective survey of our hospital in April 2013 preparation price adjustment before and after 15 months (January 2012 ~ June 2014) the preparation of the use of analysis of price adjustment and the relationship between clinical use. Results: Among the 47 kinds of preparations after the price adjustment, the dosage of 9 kinds of preparations increased, accounting for 19.15%; 38 kinds of dosage decreased, accounting for 80.85%. Conclusion: There is no direct correlation between clinical dosage and price adjustment. Hospital preparations are still an indispensable part of clinical medication. The medical insurance department urgently needs to adjust the medical insurance reimbursement policy to reduce the burden on patients.